Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. (2018)

First Author: CRyPTIC Consortium And The 100,000 Genomes Project
Attributed to:  Comprehensive Resistance Prediction for Tuberculosis: an International Consortium (CRyPTIC) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa1800474

PubMed Identifier: 30280646

Publication URI: http://europepmc.org/abstract/MED/30280646

Type: Journal Article/Review

Volume: 379

Parent Publication: The New England journal of medicine

Issue: 15

ISSN: 0028-4793